63 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 68 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 68 | Completed 63, Unknown 2, Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 5 | Completed 4, Recruiting 1 |
Follow Clarithromycin: new trials by email Literature Review of Clarithromycin trials Research Report on Clarithromycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet RSS0343 Tablet; Rifampicin Capsules, RSS0343 Tablet; Clarithromycin Tablets - Non-cystic Fibrosis Bronchiectasis、Chronic Sinusitis Without Nasal Polyps、Chronic Obstructive Pulmonary Disease | Phase 1 | Not yet recruiting | Reistone Biopharma Company Limited | 40 | 2026-07-01 | 2026-07-10 |
| Drug Interaction Study on Linaprazan Glurate Capsules Linaprazan Glurate Capsules, Bismuth Potassium Citrate Capsules, Amoxicillin Capsules - Healthy Volunteers, Patients | Phase 1 | Completed | Jiangsu Sinorda Biomedicine Co., Ltd | 56 | 2025-09-08 | 2026-01-06 |
| Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects HRS-5965 Capsules, Clopidogrel, Clarithromycin - Complement Mediated Glomerular Diseases, Hemolytic Anemia | Phase 1 | Completed | Chengdu Suncadia Medicine Co., Ltd. | 36 | 2025-07-08 | 2025-08-20 |
| A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults PF-07328948, cyclosporine, clarithromycin - Healthy Adults | Phase 1 | Completed | Pfizer | 26 | 2025-03-19 | 2026-02-02 |
| Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin Midazolam, Clarithromycin, TNP-2198 - Helicobacter Pylori Infection | Phase 1 | Completed | TenNor Therapeutics Inc. | 32 | 2024-08-26 | 2024-10-24 |
| A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants KP-001, Metformin, Midazolam - Healthy Adults | Phase 1 | Completed | Kaken Pharmaceutical | 38 | 2023-12-15 | 2025-03-07 |
| Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults DA-8010 5mg, Clarithromycin 500mg, Rifampicin 600mg - Healthy | Phase 1 | Completed | Dong-A ST Co., Ltd. | 18 | 2023-08-18 | 2024-01-25 |
| Effect of Pharmacokinetics in Healthy Chinese Subjects Mindeudesivir hydrobromide tablets and Clarithromycin tablets, Mindeudesivir hydrobromide tablets and Cyclosporine softgels - The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects | Phase 1 | Completed | Shanghai Vinnerna Biosciences Co., Ltd. | 36 | 2023-08-15 | 2025-06-29 |
| A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants Brensocatib, Clarithromycin - Healthy Volunteers | Phase 1 | Completed | Insmed Incorporated | 22 | 2023-07-28 | 2023-12-11 |
| Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin Tegoprazan, Bismuth, Amoxicilli - Healthy | Phase 1 | Completed | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | 22 | 2023-03-23 | 2023-06-23 |
| Electrophysiological Effects of Potential QT Prolonging Drugs Clarithromycin, Pimozide, Placebo (Part 1) - Drug-induced QT Prolongation, Pharmacokinetics | Phase 1 | Completed | Food and Drug Administration (FDA) | 44 | 2023-03-21 | 2023-06-22 |
| Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam Linaprazan glurate, Drug drug interaction (DDI) - Clarithromycin (Part I), Drug drug interaction (DDI) - Midazolam (Part 2) - Safety Issues, Pharmacokinetics | Phase 1 | Completed | Cinclus Pharma Holding AB | 35 | 2022-11-27 | 2025-01-03 |
| A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants LY3502970, Clarithromycin - Healthy | Phase 1 | Completed | Eli Lilly and Company | 26 | 2022-08-01 | 2026-05-27 |
| Furazolidone Quadruple Regimen Eradicate H. Pylori Infection Furazolidone, Clarithromycin - Helicobacter Pylori Infection, Eradication | Phase 1 / Phase 2 | Completed | Liaocheng People's Hospital | 493 | 2022-08-01 | 2025-02-12 |
| The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2) Givinostat, Clarithromycin - Drug Drug Interaction | Phase 1 | Completed | Italfarmaco | 20 | 2022-03-21 | 2024-08-16 |
| A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects ATI-2173, Midazolam, Clarithromycin - Drug Drug Interaction | Phase 1 | Completed | Antios Therapeutics, Inc | 36 | 2021-10-28 | 2022-02-04 |
| Effect of Clarithromycin and Rifampicin on the Pharmacokinetics of XZP-3287 in Healthy Subjects XZP-3287 combined with clarithromycin, XZP-3287 combined with rifampicin - Healthy | Phase 1 | Unknown | Xuanzhu Biopharmaceutical Co., Ltd. | 60 | 2021-07-01 | 2021-07-27 |
| A Study of Vonoprazan in Adults With Helicobacter Pylori Clarithromycin, Amoxicillin, Bismuth potassium citrate - Helicobacter Pylori | Phase 1 | Completed | Takeda | 44 | 2021-04-06 | 2023-08-31 |
| Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers JP-1366 20mg 1capsule, Amoxicillin 500Mg Cap, Clarithromycin 500Mg Tab - Helicobacter Pylori Associated Gastrointestinal Disease | Phase 1 | Completed | Onconic Therapeutics Inc. | 29 | 2020-11-18 | 2022-01-18 |
| Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies Zanubrutinib, Fluconazole, Diltiazem - B-cell Malignancies | Phase 1 | Completed | BeiGene | 26 | 2020-11-15 | 2024-10-26 |
Showing 20 of 68. Sign in to see all of them.
HIV Infections (3) · AIDS-Related Opportunistic Infections (2) · Acquired Immunodeficiency Syndrome (2) · Parkinson Disease (2) · AIDS-Related Complex (1) · Alzheimer Disease (1) · Anemia, Hemolytic (1) · Anovulation (1) · Bacterial Infections (1) · Depressive Disorder, Major (1) · Lymphoma (1) · Multiple Myeloma (1) · Mycobacterium avium-intracellulare Infection (1) · Mycoses (1) · Neoplasm Metastasis (1)
Eli Lilly and Company (4) · Boehringer Ingelheim (3) · Janssen Research & Development, LLC (3) · Mylan Pharmaceuticals Inc (3) · Takeda (3) · HK inno.N Corporation (2) · Sandoz (2) · Seoul National University Hospital (2) · Teva Pharmaceuticals USA (2) · Abbott (1) · Antios Therapeutics, Inc (1) · BeiGene (1) · Bristol-Myers Squibb (1) · CTI BioPharma (1) · Centre Hospitalier Universitaire de Saint Etienne (1)
United States (21) · South Korea (10) · China (9) · Canada (5) · Belgium (4) · Australia (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · India (1) · Japan (1) · Pakistan (1) · Portugal (1) · Russia (1)
Eric Sicard, M.D. (3) · James D Carlson, Pharm. D. (2) · Joo-Youn Cho (2) · So Ran Hong, M.D. (2) · Alla Andreeva, PhD (1) · Elena Smolyarchuk, PhD (1) · Frank Farmer, MD, PhD (1) · Henrik E Poulsen, dr. med. (1) · Husson R (1)
PMID 15470330, PMID 21480191, PMID 24919854, PMID 26872892, PMID 27928738, PMID 28783865, PMID 28800141, PMID 29846770, PMID 30352784, PMID 31030414, PMID 32274381, PMID 33062627, PMID 33128208, PMID 36480811, PMID 37393120, PMID 37440779, PMID 38826786, PMID 40948663
2014 (3), 2009 (1), 2018 (1), R01NS099535 (1)